Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial.
Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial. J Thorac Cardiovasc Surg. 2013 Jul; 146(1):124-31.